University of Birmingham scientists develop new MRI contrast agent
November 12, 2025Research and Development Diagnostics, MRI, University of Birmingham, medical imaging
Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …
Custom Pharmaceuticals launches new company for drug product development
November 12, 2025Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex
Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …
Novartis receives SMC approval for early breast cancer treatment
November 11, 2025Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland
Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …
Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers
November 10, 2025Manufacturing and Production Chiesi, Metered Dose Inhalers, Site Expansion, respiratory diseases
Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its manufacturing and industrial site in …
Richmond Pharmacology appoints Dr Edward Jackson as Medical Director
November 7, 2025CRO, Richmond Pharmacology, biotech, clinical trials
Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …
Vesper Bio reports positive topline results for dementia candidate
November 7, 2025Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia
Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …
AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders
November 7, 2025Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders
AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …
Ardena appoints new Chief Quality Officer and Chief Information Officer
November 6, 2025Ardena, CDMO, CRO, Chief Information Officer, chief quality officer
Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO) focusing on precision medicines, …
Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO
November 5, 2025Draig Therapeutics, Neuropsychiatry, neuroscience
Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …
Von Willebrand disease – increasing awareness and access to vital care
November 4, 2025Medical Communications, Research and Development European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness
Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …
Rethinking oncology trial endpoints with generalised pairwise comparisons
November 4, 2025Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology
For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …
VALANX Biotech appoints Klaus Orlinger as Chief Scientific Officer
November 4, 2025Antibody-Drug Conjugate, VALANX Biotech, drug development
VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …
The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust
November 3, 2025Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients
Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …
Five Facts about men’s mental health
October 31, 2025Medical Communications Five Facts, mental health, men’s mental health
1 While only 15.4% of men are diagnosed with a common mental health condition (CMHC’s) in the UK (compared to …
AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics
October 31, 2025AAX Biotech, Daiichi Sankyo, Opti-mAb, Seqitope
AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …
Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies
October 30, 2025Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership
Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …
Is this an Oppenheimer moment for the life sciences industry?
October 29, 2025Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health
By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …
Pharma&’s ovarian cancer therapy approved for use by NHS Scotland
October 29, 2025Pharma&, Rubraca, Scottish Medicines Consortium, nhs scotland, oncology, ovarian cancer
Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …
BioMedX launches R&D accelerator to advance women’s health
October 28, 2025Research and Development BioMedX, Gates Foundation, Women’s Health
BioMed X, an independent research institute with sites in Germany and the United States, has announced the launch of XFem …
Berlin Heals appoints Dr Eric Fain as new board member
October 28, 2025Berlin Heals, Cardiovascular Health, chronic heart failure, medtech
Berlin Heals, a clinical-stage medical device company focused on treating chronic heart failure, has appointed Dr Eric S Fain to …
